Relapsed/Refractory Follicular Lymphoma With EZH2
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Follicular Lymphoma With EZH2
| Record | Firm | Date |
|---|---|---|
| Tazemetostat for the Treatment of Relapsed/Refractory Follicular Lymphoma (NCT05467943) | Hutchmed | 2022-07-29 |
Track Relapsed/Refractory Follicular Lymphoma With EZH2 automatically
Every clearance here is in the API, with alerts when new ones post.